Levels of specific serum N-glycans identify breast cancer patients with higher circulating tumor cell counts

Background: Metastatic breast cancer (MBC) is currently an incurable condition that is primarily treated with palliative measures. Isolation of circulating tumor cells (CTCs) from the peripheral blood of these patients provides a predictive prognostic indicator, independent of the type of therapy, s...

Full description

Bibliographic Details
Main Authors: Abd Hamid, U.M (Author), Cristofanilli, M. (Author), Reuben, J.M (Author), Rudd, P.M (Author), Saldova, R. (Author)
Format: Article
Language:English
Published: Oxford University Press 2011
Subjects:
Online Access:View Fulltext in Publisher
View in Scopus